A detailed history of Invenire Partners, LP transactions in Inotiv, Inc. stock. As of the latest transaction made, Invenire Partners, LP holds 95,000 shares of NOTV stock, worth $172,900. This represents 100.0% of its overall portfolio holdings.

Number of Shares
95,000
Holding current value
$172,900
% of portfolio
100.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$9.81 - $26.17 $931,950 - $2.49 Million
95,000 New
95,000 $1.6 Billion

Others Institutions Holding NOTV

About Inotiv, Inc.


  • Ticker NOTV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 25,594,500
  • Market Cap $46.6M
  • Description
  • Inotiv, Inc. provides drug discovery and development services to the pharmaceutical, chemical, and medical device industries; and sells analytical instruments to the pharmaceutical development and contract research industries. It operates through two segments, Contract Research Services and Research Products. The Contract Research Services segme...
More about NOTV
Track This Portfolio

Track Invenire Partners, LP Portfolio

Follow Invenire Partners, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Invenire Partners, LP, based on Form 13F filings with the SEC.

News

Stay updated on Invenire Partners, LP with notifications on news.